Search
Search Results
##search.searchResults.foundPlural##
-
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3550PDF: 1422HTML: 2720 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3307PDF: 1901HTML: 3693 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2323PDF: 1021HTML: 4980 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4160PDF: 1295HTML: 2118Table 1: 219 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1524PDF: 1006HTML: 511 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3017PDF: 1053HTML: 1242 -
SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
1846PDF: 1053HTML: 2078cover: 200Table 1. Co-morbidities associated with Sphingomonas paucimobilis infections.: 204Figure 1. The antimicrobial susceptibility patterns of Sphingomonas paucimobilis isolated from clinical specimens: 1718title page: 203 -
-
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4488PDF: 954HTML: 1357Table1: 203 -
WHAT ARE FUNGAL INFECTIONS?
4314PDF: 2472HTML: 27694de Pauw: 263 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4855PDF: 1601HTML: 2261Untitled: 251Untitled: 264Untitled: 284Untitled: 235Untitled: 253 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1898PDF: 1146HTML: 10750Untitled: 212 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2420PDF: 996HTML: 11163 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5385PDF: 1375HTML: 2866Cover letter: 224 -
THE EMERGING RESISTANCE IN NOSOCOMIAL URINARY TRACT INFECTIONS: FROM THE PEDIATRICS PERSPECTIVE.
2172PDF: 991HTML: 253The emerging resistance in nosocomial urinary tract infections: from the pediatrics perspective: 261 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2269PDF: 752HTML: 2144Untitled: 245Untitled: 170Untitled: 201Untitled: 174Untitled: 191Untitled: 200Untitled: 204 -
-
-
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
195PDF: 649HTML: 63 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3796PDF: 1303HTML: 3926Untitled: 256Untitled: 290 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1753PDF: 827HTML: 876jdoe, table 2 infections CML .doc: 215jdoe, table 1 infections CML .doc: 202 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2482PDF: 1221HTML: 1046 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2470PDF: 1471HTML: 2021 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2217PDF: 1036HTML: 4092Cover Letter: 241Figure 1: 255Figure 2: 248Table 1: 229 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1868PDF: 759HTML: 425 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4404PDF: 1425HTML: 2187







